Industry litigation – Page 13
-
BusinessDuPont found liable in second of 3400 cancer cases
US jury awards over $5 million in claim linked to PFOA emitted by DuPont plant
-
BusinessBrexit uncertainty ripples across regulation
What might leaving the EU mean for medicines regulation, the Unified Patent Court, and the UK’s participation in Reach?
-
BusinessUnpicking doctor payments
Accepting even small meals from drug industry reps appears to influence doctors’ prescription rates
-
BusinessLies and deception see Astellas UK suspended by trade body
Company promoted drugs inappropriately and misled regulators in the resulting investigation
-
BusinessHarvard settles with ex-student over drug royalties
Student claimed university forced him to accept unfair cut in patent deal
-
BusinessUS biotech director accused of insider trading
Biostatistics chief at Akebia charged with securities fraud
-
BusinessMetals boss admits illegal export plot
Global Metallurgy chief conspired to export restricted metals to Iran
-
BusinessJudge voids Merck & Co’s $200m patent claim
‘Serious misconduct’ kills case over Gilead’s hepatitis C drugs
-
BusinessVertellus enters bankruptcy
Chemical maker files for Chapter 11 bankruptcy protection for its US operations and plans to auction the business
-
BusinessIndia hit hard by US regulatory sanctions
Data integrity issues have led to punitive measures, but companies are taking measures to improve
-
BusinessUS tax relief law benefits chemical makers
Bill provides mechanism to waive import tariffs on materials not available from domestic suppliers
-
BusinessDeadly US fertiliser plant blast was deliberately set
Fire that caused West Fertilizer explosion was a ‘criminal act,’ US agency concludes
-
BusinessDaiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
-
BusinessUS treasury rules scupper Pfizer–Allergan merger
Government aims to crack down on corporate tax avoidance through ‘inversion’ deals
-
BusinessDuPont shutters US plant where leak killed four workers
La Porte plant will not reopen after fatal methyl mercaptan leak in 2014
-
BusinessCalifornian hazard warning website criticised
Site providing information related to state’s Proposition 65 law is ‘inaccurate’ says industry association
-
NewsBP’s long legal battle over Deepwater disaster ends
Judge finalises BP’s $20 billion settlement over Gulf of Mexico oil spill
-
BusinessGilead loses to Merck & Co in hepatitis C drug dispute
US court upholds Merck’s claim to patents related to blockbuster drugs
-
BusinessIndian whistleblower pushes for regulatory reform
Although denied a hearing by India’s supreme court, Dinesh Thakur wants to shake up pharmaceutical safety laws
-
BusinessIndia bans 344 combination drugs
Manufacturers appeal to courts to allow continued sales of products the government deems risky